Alembic Pharma’s arm receives USFDA approval for Fenofibrate Tablets

Date: 12-02-2019

Alembic Pharmaceuticals’ wholly owned step down subsidiary -- Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Tricor Tablets, 54 mg and 160 mg, of AbbVie Inc. (AbbVie)

Fenofibrate Tablets USP, 54 mg and 160 mg are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidaemia and for treatment of adult patients with severe hypertriglyceridemia.

Fenofibrate Tablets USP, 54 mg and 160 mg have an estimated market size of $92 million for twelve months ending December 2018 according to IQVIA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Latest Financials

Latest Financials

 - Alembic Pharmaceuticals Ltd.

  Standalone Consolidated
TTM EPS (Rs) 34.36 29.4
TTM Sales (Rs. Cr.) 3,650 3,861
BVPS (Rs.)
The total value that a company will fetch upon liquidation (if it is closed down), after settling all obligations is called its Book Value. Book value of a company includes only tangible assets. Book value allocated to each outstanding share is called Book Value per share
138.32 138.16
Reserves (Rs. Cr.)
The term reserve represents a part of shareholders' equity, except for basic share capital. Reserves are created from retained earnings and shareholders' contributions in the form of share premium etc.
2,570 2,567
P/BV
Price to Book Value is the ratio of stock's market value to its book value. It gives some idea of whether investors are paying too much for what would be left if the company went bankrupt immediately. To get high returns, it is advisable to invest in a company which satisfies all the criteria set by MoneyWorks4me and which has low price to book value ratio.
3.84 3.85
PE
It is the ratio of market price and earnings per share. It shows what the market is willing to pay for the company's earnings. To get high returns it is advisable to invest in the company which satisfies all the criteria set by MoneyWorks4me and which has low price to earnings ratio as compared to the industry.
15.46 18.08
From the Market
52 Week High / Low (Rs) 664.00/412.40
All Time High / Low (Rs) 791.70/34.00
Volume Traded 14,064
Market Cap (Rs. Cr.) 10,017
Equity (Rs. Cr.) 37.7
Face Value (Rs) 2
Industry PE
Industry price to earnings per share tells on an average, what the market is willing to pay for overall earnings in that industry. It can be used as a benchmark price to earnings ratio for the companies in that industry.
29.37
Return to Top
Puchho Befikar
Puchho Befikar with Emoji
Want to know if Alembic Pharmaceuticals Ltd. is right? And more..
Request Call Back
Invalid Mobile Number
Thanks.
We will call you shortly.